SciELO - Scientific Electronic Library Online

 
vol.37 número5Eficiencia del inicio con ambrisentan frente a bosentan en el tratamiento de la hipertensión arterial pulmonarAnálisis de la prescripción de oxigenoterapia continua domiciliaria tras intervención farmacéutica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Farmacia Hospitalaria

versión On-line ISSN 2171-8695versión impresa ISSN 1130-6343

Resumen

MORENO-RAMIREZ, David; FERRANDIZ, Lara; RAMIREZ-SOTO, Gabriel  y  MUNOYERRO, Mª Dolores. Quantitative analysis of drug expenditures variability in dermatology units. Farm Hosp. [online]. 2013, vol.37, n.5, pp.366-371. ISSN 2171-8695.  https://dx.doi.org/10.7399/FH.2013.37.5.636.

Background: Variability in adjusted drug expenditures among clinical departments raises the possibility of difficult access to certain therapies at the time that avoidable expenditures may also exist. Nevertheless, drug expenditures are not usually applied to clinical practice variability analysis. Aims: To identify and quantify variability in drug expenditures in comparable dermatology department of the Servicio Andaluz de Salud. Methods: Comparative economic analysis regarding the drug expenditures adjusted to population and health care production in 18 dermatology departments of the Servicio Andaluz de Salud. The 2012 cost and production data (homogeneous production units -HPU-)were provided by Inforcoan, the cost accounting information system of the Servicio Andaluz de Salud. Results: The observed drug expenditure ratio ranged from 0.97€/inh to 8.90€/inh and from 208.45€/HPU to 1,471.95€/ HPU. The Pearson correlation between drug expenditure and population was 0.25 and 0.35 for the correlation between expenditure and homogeneous production (p=0.32 and p=0,15, respectively), both Pearson coefficients confirming the lack of correlation and arelevant degree of variability in drug expenditures. Conclusion: The quantitative analysis of variability performed through Pearson correlation has confirmed the existence of drug expenditure variability among comparable dermatology departments.

Palabras clave : Health expenditures; Clinical practice variation; Cost-accounting; Dermatology.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons